Mayne Pharma sta testando una crema topica per l’Ittiosi Lamellare
La Fondazione Americana FIRST ci ha informati che Mayne Pharma sta conducendo una nuova sperimentazione clinica per l’ Ittiosi Lamellare. Si tratta di studio globale con lo scopo di verificare gli effetti di una nuova crema topica sperimentale che è stata specificamente formulata e progettata per questa forma di ittiosi.
Queste sono le specifiche della sperimentazione:
Durata dello studio: 12 settimane, con la possibilità di continuare per altre 12 settimane (fino a 24 settimane)
Età dei pazienti: dai 12 anni in su.
Trattamento ricevuto: tutti i partecipanti allo studio riceveranno “casualmente” il farmaco in studio con il principio attivo oppure il placebo per le prime 12 settimane (2/3 probabilità di ricevere farmaci in studio con ingrediente attivo). I partecipanti allo studio che completano le prime 12 settimane di studio e desiderano continuare per altre 12 settimane riceveranno il farmaco di studio con il principio attivo (nessuno riceverà placebo).
Frequenza del trattamento: due volte a settimana.
Lo studio sta attualmente reclutando attivamente in 9 paesi tra i quali purtroppo non c’è l’Italia e si tratta di: Stati Uniti, Canada, Australia, Francia, Spagna, Germania, Regno Unito, Ucraina, Israele.
Chi fosse in possesso delle caratteristiche richieste e volesse partecipare a questa sperimentazione può chiedere di aderire anche se non propriamente vicino ad un centro di sperimentazione clinica partecipante. La vicinanza potrà comunque tornare utile per verificare meglio i risultati e le possibilità nonché per facilitare l’organizzazione del viaggio completamente sovvenzionata.
Per ulteriori informazioni su come partecipare, ammissibilità e altri dettagli di studio potete visitare il sito www.ichthyosisstudy.com o contattare il centro studi più vicino.
United States:
YALE UNIVERSITY
Principal Investigator: KEITH CHOATE
Study Coordinator: MAHIN DAWOOD
Address: New Haven, CT
Contact: mahin.dawood@yale.edu ; 203.789.1249
CHILDREN’S HOSPITAL OF PHILADELPHIA
Principal Investigator: LESLIE CASTELO-SOCCIO
Study Coordinator: LISA CATANOSO
Address: Philadelphia, PA
Contact: catanosol@email.chop.edu ; 215.590.2169
DAWES FRETZIN CLINICAL RESEARCH GROUP, LLC
Principal Investigator: KENNETH DAWES
Study Coordinator: SARAH L. RAGAN
Address: Indianapolis, IN
Contact: sragan@ecommunity.com ; 317.516.5030
TCR MEDICAL CORPORATION
Principal Investigator: NEAL BHATIA
Study Coordinator: NICKY YAGUBOVA
Address: San Diego, CA
Contact: nyagubova@therapeuticsresearch.com ; 858.571.6800
DERMASSOCIATES, PC
Principal Investigator: BEN LOCKSHIN
Study Coordinator: THOMAS BLONDO
Address: Rockville, MD
Contact: tblondo@dermassociates.com ; 301.355.3183
MEDICAL UNIVERSITY OF SOUTH CAROLINA
Principal Investigator: LARA WINE LEE
Study Coordinator: CHARNELE HANDY
Address: Charleston, SC
Contact: handyc@musc.edu ; 843.792.3021
TEXAS DERMATOLOGY AND LASER SPECIALISTS
Principal Investigator: JOHN BROWNING
Address: San Antonio, TX
Contact: drbrowning@texasdls.com ; 210.852.2779
CHILDREN’S HOSPITAL COLORADO
Principal Investigator: ANNA BRUCKNER
Study Coordinator: KATHLEEN PEOPLES
Address: Aurora, CO
Contact: kathleen.peoples@childrenscolorado.org ; 720.777.0955
MASSACHUSETTS GENERAL HOSPITAL – CLINICAL UNIT FOR RESEARCH TRIALS IN SKIN (CURTIS)
Principal Investigator: EVELYN LILLY
Study Coordinator: ELVIDA ARIAS
Address: Boston, MA
Contact: eyarias@mgh.harvard.edu ; 617.726.5066
NORTHSHORE UNIVERSITY HEALTHSYSTEM
Principal Investigator: STEPHANIE MEHLIS
Study Coordinator: JUDY SPOLARICH-KROLL
Address: Skokie, IL
Contact: jspolarich-kroll@northshore.org ; 847.663.8530
Canada
THE HOSPITAL FOR SICK CHILDREN
Principal Investigator: ELENA POPE
Study Coordinator: HANNA FADZEYEVA
Address: Toronto, M5G 1X8
Contact: hanna.fadzeyeva@sickkids.ca
Australia
ROYAL CHILDREN’S HOSPITAL
Principal Investigator: JOHN SU
Study Coordinator: JEMIMAH MATEER
Address: Parkville, 3052
Contact: jemimah.mateer@mcri.edu.au
PREMIER SPECIALISTS PTY LTD.
Principal Investigator: DEDEE MURRELL
Study Coordinator: HELEN DICKENSON-PANAS
Address: Sydney, 2217
Contact: d.murrell@unsw.edu.au ; premierspecialiststrials@gmail.com
VERACITY CLINICAL RESEARCH
Principal Investigator: LYNDA SPELMAN
Study Coordinator: KURT DAVIDSON
Address: Brisbane, 4102
Contact: kdavidson@veracityclinicalresearch.com.au
EASTERN HEALTH MONASH UNIVERSITY
Principal Investigator: JOHN SU
Study Coordinator: BELINDA DRESSER
Address: Box Hill, 3111
Contact: belinda.dresser@monash.edu
France
CHU DE TOULOUSE – HOPITAL LARREY
Principal Investigator: JULIETTE MAZEREEUW-HAUTIER
Study Coordinator: HÉLÈNE TEXIER
Address: Toulouse, 31059
Contact: texier.h@chu-toulouse.fr
DERMATOLOGIE PÉDIATRIQUE / PÉDIATRIE GÉNÉRALE
Principal Investigator: CHRISTINE BODEMER
Study Coordinator: MIRANDOLIE FRIDA
Address: Paris, 75015
Contact: mirandolie.frida@institutimagine.org
CHU CHARLES NICOLLE
Principal Investigator: ANNE BENEDICTE DUVAL MODESTE
Study Coordinator: ORLANE DEBOVES
Address: Rouen, 76031
Contact: orlane.deboves@chu-rouen.fr
Spain
HOSPITAL CLÍNIC DE BARCELONA
Principal Investigator: SUSANA PUIG
Study Coordinator: PABLO IGLESIAS
Address: Barcelona, 08036
Contact: pabloiglesiasgarcia@msn.com
HOSPITAL NIÑO JESÚS
Principal Investigator: ANGELA HERNANDEZ
Study Coordinator: NURIA VENTOSINO
Address: Madrid, 28009
Contact: nuria.ventosino@salud.madrid.org
CLÍNICA UNIVERSIDAD DE NAVARRA
Principal Investigator: PEDRO REDONDO
Study Coordinator: IRENE BARRIENTOS
Address: Pamplona (Navarra), 31008
Contact: ibarrientos@unav.es
CLÍNICA UNIVERSIDAD DE NAVARRA (MADRID)
Principal Investigator: PEDRO REDONDO
Study Coordinator: MARILUZ MONTESINOS
Address: Madrid, 28027
Contact: mmontesinos@unav.es
Germany
UNIVERSITÄTSKLINKUM FRANKFURT
Principal Investigator: ANDREAS PINTER
Study Coordinator: KARINA TAMM
Address: Frankfurt, 60590
Contact: karina.tamm@kgu.de
CHARITE – UNIVERSITAETSMEDIZIN BERLIN
Principal Investigator: URIKE BLUME-PEYTAVI
Study Coordinator: ANNETTE ANDRUCK
Address: Berlin, 10117
Contact: annette.andruck@charite.de
LUDWIG-MAXIMILIANS UNIVERSITY
Principal Investigator: KATHRIN GIEHL
Study Coordinator: JULIA DILLARD
Address: Munich, 80337
Contact: julia.dillard@med.uni-muenchen.de
KATH. KINDERKRANKENHAUS WILHELMSTIFT
Principal Investigator: PETER HOEGER
Study Coordinator: ANDREA BRITSCH
Address: Hamburg, 22149
Contact: a.britsch@kkh-wilhelmstift.de
UNIVERSITATSMEDIZIN ROSTOCK
Principal Investigator: SUSEN RODE
Study Coordinator: GESINE BANDOW
Address: Rostock, 18057
Contact: gesine.bandow@med.uni-rostock.de
UK
ROYAL LONDON HOSPITAL BARTS HEALTH NHS TRUST
Principal Investigator: EDEL O’TOOLE
Study Coordinator: PAUL FOSTER COFIE
Address: London, E11BB
Contact: paulfoster.cofie@nhs.net
Israel
TEL AVIV SOURASKY MC
Principal Investigator: LIAT SAMUELOV
Study Coordinator: ZVI ISMAKIV
Address: Tel Aviv, 6423906
Contact: zviis@tlvmc.gov.il
Ukraine
MEDICAL CENTER OF PRIVATE ENTERPRISE “DZERKALO”
Principal Investigator: TETYANA SVYATENKO
Study Coordinator: OLHA STATKEVYCH
Address: Dnipro, 49000
Contact: statkevycholha@ukr.net
TDC PE “ASCLEPIUS”
Principal Investigator: YURIY ANDRASHKO
Study Coordinator: ROMAN YAREMKEVYCH
Address: Uzhhorod, 88000
Contact: r.yaremkevych@gmail.com
DNIPROPETROVSK STATE HOSPITAL OF DERMATOVENEROLOGY
Principal Investigator: ANATOLY DYUDYUN
Study Coordinator: NATALIIA POLION
Address: Dnipro, 49074
Contact: nnpolion@ua.fm
MEDICAL CENTER “FAMILY MEDICINE CLINIC”
Principal Investigator: NATALIIA KUZNETSOVA
Address: Dnipro, 49600
Contact: trials.ksm@gmail.com
MILITARY HOSPITAL (MILITARY UNIT A3309) OF MILITARY-MEDICAL CLINICAL CENTRE OF SOUTHERN REGION
Principal Investigator: NATALIYA REZNICHENKO
Address: Zaporizhzhya, 69063
Contact: n.reznichenkog@gmail.com